-- Elevance Health (ELV) shares rose 2.5% in Wednesday trading after BofA Securities upgraded the stock to buy from neutral, with a price target of $435.
Trading volume stood at about 1.4 million shares, compared with a daily average of over 1.9 million.
Price: $371.74, Change: $+9.00, Percent Change: +2.48%